Structure-activity relationship approaches and applications

Environmental Toxicology and Chemistry

Volumn 22, Issue 8, 2003, Pages 1680-1695

  Tong, Weida ^a   Welsh, William J ^b   Shi, Leming ^c   Fang, Hong ^d   Perkins, Roger ^d  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^b RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^c BASF CORPORATION   (United States)

^d Logicon ROW Sciences   (United States)

Author keywords

Chemometrics; Computational toxicology; Predictive toxicology; Structure activity relationship

Indexed keywords

COMPUTER SOFTWARE; DATA REDUCTION; DRUG PRODUCTS; MOLECULAR STRUCTURE; TOXIC MATERIALS;

CHEMOMETRY;

ENVIRONMENTAL PROTECTION;

CHEMICAL ANALYSIS; CHEMICAL STRUCTURE; CHEMOMETRIC ANALYSIS; COMPUTER PROGRAM; DATA ANALYSIS; DRUG INDUSTRY; LD 50; MATHEMATICAL MODEL; METHODOLOGY; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REVIEW; SCORING SYSTEM; STATISTICAL MODEL; STRUCTURE ACTIVITY RELATION; TECHNOLOGY; TOXICITY; TOXICOLOGY; FORECASTING; THEORETICAL MODEL;

FORECASTING; MODELS, THEORETICAL; RESEARCH DESIGN; SOFTWARE; STRUCTURE-ACTIVITY RELATIONSHIP; TOXICOLOGY;

EID: 0142121263     PISSN: 07307268     EISSN: None     Source Type: Journal    
DOI: 10.1897/01-198     Document Type: Review

References (157)

1. Warr WA. 1997. Combinatorial chemistry and molecular diversity: An overview. J Chem Inf Comput Sci 37:134-140.
2. Williard X, Pop I, Bourel L, Horvath D, Baudelle R, Meynyk P, Deprez B, Tartar A. 1996. Combinatorial chemistry: A rational approach to chemical diversity. Eur J Med Chem 31:87-98.
3. Chee M, Yang R, Hubbell E, Berno A, Huang XC, Stern D, Winkler J, Lockhart DJ, Morris MS, Fodor SP. 1996. Accessing genetic information with high-density DNA arrays. Science 274:610-614.
4. Covacci A, Kennedy GC, Cormack B, Rappuoli R, Falkow S. 1997. From microbial genomics to meta-genomics [review]. Drug Dev Res 41:180-192.
5. Ramsay G. 1998. DNA chips - state-of-the-art [review]. Nat Biotechnol 16:40-44.
6. Wallace RW. 1997. DNA on a chip - serving up the genome for diagnostics and research. Mol Med Today 3:384-389.
7. Wang DG, Fan JB, Siao CJ, Berno A, Young P, Sapolsky R, Ghandour G, Perkins N, Winchester E, Spencer J, Kruglyak L, Stein L, Hsie L, Topaloglut T, Hubbell E, Robinsin E, Mittman M, Morris MS, Shen N, Kilburn D, Rioux J, Nusbaum C, Rozen S, Hudson TJ, Lipshutz R, Chee M, Lander ES. 1998. Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome. Science 280:1077-1082.
8. Sosnowski RG, Tu E, Butler WF, O'Connell JP, Heller MJ. 1997. Rapid determination of single base mismatch mutations in DNA hybrids by direct electric field control. Proc Natl Acad Sci USA 94:1119-1123.
9. Nuwaysir EF, Bittner M, Trent J, Barrett JC, Afshari CA. 1999. Microarrays and toxicology: The advent of toxicogenomics. Mol Carcinog 24:153-159.
10. MacBeath G, Schreiber SL. 2000. Printing proteins as microarrays for high-throughput function determination. Science 289:1760-1763.
11. Martin EJ, Spellmeyer DC, Critchlow RE Jr, Blaney JM. 1997. Does combinatorial chemistry obviate computer-aided drug design? In Lipkowitz KB, Boyd DB, eds, Reviews in Computational Chemistry, Vol 10. VCH, New York, NY, USA pp 75-100.
12. Blaney JM, Martin EJ. 1997. Computational approaches for combinatorial library design and molecular diversity analysis. Curr Opin Chem Biol 1:54-59.
13. Brown RD, Martin YC. 1997. Designing combinatorial library mixtures using a genetic algorithm. J Med Chem 40:2304-2313.
14. Martin EJ, Blaney JM, Siani MA, Spellmeyer DC, Wong AK, Moos WH. 1995. Measuring diversity: Experimental design of combinatorial libraries for drug discovery. J Med Chem 38:1431-1436.
15. Barnard JM, Downs GM. 1992. Clustering of chemical structures on the bases of two-dimensional similarity measures. J Chem Inf Comput Sci 32:644-649.
16. Brown RD, Martin YC. 1996. Use of structure-activity data to compare structure-based clustering methods and descriptors for use in compound selection. J Chem Inf Comput Sci 36:572-584.
17. Downs GM, Willett P, Fiasanick W. 1994. Similarity searching and clustering of chemical-structure databases using molecular property data. J Chem Inf Comput Sci 34:1094-1102.
18. Downs GM, Willett P. 1995. Clustering of chemical structure databases for compound selection. In van de Waterbeemd H, ed, Advanced Computer-Assisted Techniques in Drug Discovery, Vol 3-Methods and principles in medicinal chemistry. VCH, Weinheim, Germany, pp 111-130.
19. Hodes L. 1981. Computer-aided selection of compounds for antitumor screening: Validation of a statistical-heuristic method. J Chem Inf Comput Sci 21:128-132.
20. Hodes L. 1989. Clustering a large number of compounds. 1. Establishing the method on an initial sample. J Chem Inf Comput Sci 29:66-71.
21. Shemetulskis NE, Dunbar JB Jr, Dunbar BW, Moreland DW, Humblet C. 1995. Enhancing the diversity of a corporate database using chemical database clustering and analysis. J Comput-Aided Mol Des 9:407-416.
22. Bawden D. 1987. Similarity and Clustering in Chemical Information Systems. John Wiley, New York, NY, USA, pp 1-254.
23. Lewis RA, Mason JS, McLay IM. 1997. Similarity measures for rational set selection and analysis of combinatorial libraries: The diverse property-derived (DPD) approach. J Chem Inf Comput Sci 37:599-614.
24. Matter H. 1997. Selecting optimally diverse compounds from structure databases: A validation study of two-dimensional and three-dimensional molecular descriptors. J Med Chem 40:1219-1229.
25. Scherf U, Ross DT, Waltham M, Smith LH, Lee JK, Tanabe L, Kohn KW, Reinhold WC, Myers TG, Andrews DT, Scudiero DA, Eisen MB, Sausville EA, Pommier Y, Botstein D, Brown PO, Weinstein JN. 2000. A gene expression database for the molecular pharmacology of cancer. Nat Genet 24:236-244.
26. Lawson RG, Jurs PC. 1990. Cluster analysis of acrylates to guide sampling for toxicity testing. J Chem Inf Comput Sci 30:137-144.
27. Johnson M, Maggiora GM. 1990. Concepts and Applications of Molecular Similarity. John Wiley. New York, NY, USA.
28. Feldman A, Hodes L. 1975. An efficient design for chemical structure searching. 1. The screens. J Chem Inf Comput Sci 15:147-152.
29. Hodes L. 1976. Selection of descriptors according to discrimination and redundancy. Application to chemical substructure searching. J Chem Inf Comput Sci 16:88-93.
30. Hodes L. 1981. Selection of molecular fragment feactures for structure-activity studies in antitumor screening. J Chem Inf Comput Sci 21:132-136.
31. Barnard JM, Downs GM. 1997. Chemical fragment generation and clustering software. J Chem Inf Comput Sci 37:141-142.
32. Downs GM, Barnard JM. 1997. Techniques for generating descriptive fingerprints in combinatorial libraries. J Chem Inf Comput Sci 37:59-61.
33. Wipke WT Krishnan S, Ouchi GI. 1978. Hash functions for rapid storage and retrieval of chemical structures. J Chem Inf Comput Sci 18:32-37.
34. Knuth D. 1973. The Art of Computer Programming: Sorting and Searching. Addison-Wesley, Reading, MA, USA.
35. Martin YC, Bures MG, Willett P. 1990. Searching databases of three-dimensional structures. In Lipkowitz KB, Boyd DB, eds, Reviews in Computational Chemistry, Vol 1. VCH, New York, NY, USA, pp 213-263.
36. Good AC, Mason JS. 1996. Three-dimensional structure datase searches. In Lipkowitz KB, Boyd DB, eds, Reviews in Computational Chemistry, Vol 7. VCH, New York, NY, USA, pp 67-117.
37. Klopman G. 1992. Multicase: A hierarchical computer automated structure evaluation program. Quant Struct-Act Relat 11:176-184.
38. Klopman G, Shi LM, Ramu A. 1997. Quantitative structure-activity relationship of multidrug resistance reversal agents. Mol Pharmacol 52:323-334.
39. Tong W, Lowis DR, Perkins R, Chen Y, Welsh WJ, Goddette DW, Heritage TW, Sheehan DM. 1998. Evalualion of quantitative structure-activity relationship methods for large-scale prediction of chemicals binding to the estrogen receptor. J Chem Inf Comput Sci 38:669-677.
40. Tong W, Perkins R, Strelitz R, Collantes ER, Keenan S, Welsh WJ, Branham WS, Sheehan DM. 1997. Quantitative structure-activity relationships (QSARs) for estrogen binding to the estrogen receptor: Predictions across species. Environ Health Perspect 105:1116-1124.
41. Hong H, Tong W, Fang H, Shi L, Qian X, Wu J, Perkins R, Walker JD, Braham W, Sheehan D. 2002. Prediction of estrogen receptor binding for 58,000 chemicals using an integrated computational approach. Environ Health Perspect 110:29-36.
42. Shi LM, Fan Y, Myers TG, O'Conner PM, Paull KD, Friend SH, Weinstein JN. 1998. Mining the nci anticancer drug discovery databases: Genetic function approximation for the QSAR study of anticancer ellipticine analogues. J Chem Inf Comput Sci 38:189-199.
43. Karelson M, Lobanov VS, Katritzky AR. 1996. Quantum-chemical descriptors in QSAR/QSPR studies. Chem Rev 96:1027-1043.
44. Tong W, Collantes ER, Chen Y, Welsh WJ. 1996 A comparative molecular field analysis study of n-benzylpiperidines as acetylcholinesterase inhibitors. J Med Chem 39:380-387.
45. Tong W, Collantes ER, Welsh WJ, Berglund BA, Howlett AC. 1998. Derivation of a pharmacophore model for anandamide using constrained conformational searching and comparative molecular field analysis. J Med Chem 41:4207-4215.
46. Tong W, Perkins R, Sheehan DM. 1999. Perspectives on three-dimensional quantitative structure-activity relationship (3D-QSAR)/comparative molecular field analysis (CoMFA) in determining estrogenic effects. Japanese Chemistry Today 2:50-57.
47. Tong W, Perkins R, Xing L, Welsh WJ, Sheehan DM. 1997. QSAR models for binding of estrogenic compounds to estrogen receptor alpha and beta subtypes. Endocrine 138:4022-5.
48. Hammett LP. 1940. Physical Organic Chemistry. McGraw-Hill, New York, NY, USA.
49. Dietrich SW. Dreyer ND, Hansch C, Bentley DL. 1980. Confidence interval estimators for parameters associated with quantitative structure-activity relationships. J Med Chem 23:1201-1205.
50. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. 1997. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Delivery Rev 23:3-25.
51. Fang H, Tong W, Shi L, Blair R, Perkins R, Branham WS, Dial SL, Moland CL, Sheehan DM. 2001. Structure activity relationship for a large diverse set of natural, synthetic and environmental chemicals. Chem Res Toxicol 14:280-294.
52. Leo A, Hansch C, Elkins D. 1971. Partition coefficients and their uses. Chem Rev 71:525-616.
53. Hansch C, Kim D, Leo AJ, Novellino E, Silipo C, Vittoria A. 1989. Toward a quantitative comparative toxicology of organic compounds. Crit Rev Toxicol 19:185-226.
54. Kellogg GE, Abraham DJ. 2000. Hydrophobicity: Is logP(o/w) more than the sum of its parts? Eur J Med Chem 35:651-661.
55. Hansch C, Leo A. 1979. Substituent Constraints for Correlation Analysis in Chemistry and Biology. Wiley lnterscience, New York, NY, USA.
56. Leo A. 1993. Calculating logpoct from structures. Chem Rev 93:1281-1306.
57. Hansch C, Leo A. 1995. Exploring QSAR - Fundamentals and Applications in Chemistry and Biology. American Chemical Society, Washington, DC, USA.
58. Ghose A, Crippen G. 1986. Atomic physicochemical parameters for three-dimensional structure-directed quantitative structure-activity relationships. I. Partition coefficients as a measure of hydrophobicity. J Med Chem 7:565-578.
59. Ghose AK, Prichett A, Crippen GM. 1988. Atomic physicochemical parameters for three-dimensional structure-directed quantitative structure-activity relationships. III. Modeling hydrophic interactions. J Comput Chem 9:80-90.
60. Viswanadhan VN, Ghose AK, Revankar GR, Robins RK. 1989. Atomic physicochemical parameters for three-dimensional structure-directed quantitative structure-activity relationships. 4. Additional parameters for hydrophobic and dispersive interactions and their application. J Chem Inf Comput Sci 29:163-172.
61. Rekker RE 1977. The Hydrophobic Fragment Constant. Elsevier, New York, NY, USA.
62. Wang R, Fu Y, Lai L. 1997. A new atom-additive method for calculating partition coefficients. J Chem Inf Comput Sci 37:615-621.
63. Chou JT, Jurs PC. 1979. Computer-assisted computation of partition coefficient from molecular structures using fragment constrants. J Chem Inf Comput Sci 19:172-178.
64. Suzuki T, Kudo Y. 1990. Automatic logP estimation based on combined additive modeling methods. J Comput-Aided Mol Des 4:155-198.
65. Moriguchi I, Hirono S, Liu Q, Nakagome I, Matsushita Y. 1992. Simple method of calculating octanol/water partition coefficient. Chem Pharm Bull 40:127-130.
66. Klopman G, Wang S. 1992. A computer automated structure evaluation (CASE) approach to calculation of partition coefficient. J Comput Chem 12:1025-1032.
67. Klopman G, Li J-Y, Wang S, Dimayuga M. 1994. Computer automated logp calculation based on an extended group contribution approach. J Chem Inf Comput Sci 34:752-781.
68. Kamlet MJ, Doherty RM, Abboud JL, Abraham MH, Taft RW. 1986. Linear solvation energy relationships: 36. Molecular properties governing solubilities of organic nonelectrolytes in water. J Pharm Sci 75:338-349.
69. Kamlet MJ, Doherty R, Abraham M, Marcus Y, Taft R. 1988. Linear solvation energy relationships. 46. An improved equation for correlation and prediction of octanol/water partition coefficients of organic nonelectrolytes (including strong hydrogen bond donor solutes). J Phys Chem 92:5244-5255.
70. Meylan W, Howard P. 1995. Atom/fragment contribution method for estimating octanol-water partition coefficients. J Pharm Sci 8:83-92.
71. Tetko IV, Tanchuk VY, Kasheva TN, Villa AE. 2001. Internet software for the calculation of the lipophilicity and aqueous solubility of chemical compounds. J Chem Inf Comput Sci 41:246-252.
72. Calleja MC, Geladi P, Persoone G. 1994. QSAR models for predicting the acute toxicity of selected organic chemicals with diverse structures to aquatic non-vertebrates and humans. SAR/QSAR Environ Res 2:193-234.
73. Mazerska Z, Augustin E, Dziegielewski J, Cholody MW, Konopa J. 1996. QSAR of acridines, III. Structure-activity relationship for antitumour imidazoacridinones and intercorrelations between in vivo and in vitro tests. Anti-Cancer Drug Des 11:73-88.
74. Bursi R, Dao T, van Wijk T, de Gooyer M, Kellenbach E, Verwer P. 1999. Comparative spectra analysis (CoSA): Spectra as three-dimensional molecular descriptors for the prediction of biological activities. J Chem Inf Comput Sci 39:861-867.
75. Beger RD, Freeman JP, Lay JO Jr, Wilkes JG, Miller DW. 2001. Use of 13c nmr spectrometric data to produce a predictive model of estrogen receptor binding activity. J Chem Inf Comput Sci 41:219-224.
76. Kauvar LM, Higgins DL, Villar HO, Sportsman JR, Engqvist-Goldstein AE, Bukar R, Bauer KE, Dilley H, Rocke DM. 1995. Predicting ligand binding to proteins by affinity fingerprinting. Chem Biol 2:107-118.
77. Kauvar LM, Higgins DL, Villar HO, Sportsman JR, Engqvist-Goldstein A, Buckar R, Bauer KE, Dilley H, Rocke DM. 1995. Predicting ligand binding to proteins by affinity fingerprinting, Chem Biol 2:107-118.
78. Nuwaysir EF, Bittner M, Trent J, Barrett JC, Afshari CA. 1999. Microarrays and toxicology: The advent of toxicogenomics. Mol Carcinog 24:153-159.
79. Marshall A, Hodgson J. 1998. DNA chips - An array of possibilities. Nat Biotechnol 16:27-31.
80. Livache T, Fouque B, Roget A, Marchand J, Bidan G, Teoule R, Mathis G. 1998. Polypyrrole DNA chip on a silicon device - example of hepatitis c virus genotyping. Anal Biochem 255:188-194.
81. Boyd MR. 1989. Status of the nci preclinical antitumor drug discovery screen. In DeVita VT, Hellman S, Rosenberg SA, eds, Cancer: Principles and Practice of Oncology Update, Vol 3. Lippincott Williams & Wilkins, Philadelphia, PA, USA, pp 1-12.
82. Boyd MR, Paull KD. 1995. Some practical considerations and applications of the national cancer institute in vitro anticancer drug discovery screen. Drug Dev Res 34:91-109.
83. Boyd MR. 1997. The NCI in vitro anticancer drug discovery screen: Concept, implementation, and operation, 1985-1995. In Teicher BA, ed, Anticancer Drug Development Guide: Preclinical Screening, Clinical Trials, and Approval. Humana, Totowa, NJ, USA, pp 23-42.
84. Paull KD, Shoemaker RH, Hodes L, Monks A, Scudiero DA, Rubinstein L, Plowman J, Boyd MR. 1989. Display and analysis of patterns of differential activity of drugs against human tumor cell lines: Development of mean graph and compare algorithm. J Natl Cancer Inst 81:1088-1092.
85. Paull KD, Hamel E, Malspeis L. 1995. Prediction of biochemical mechanism of action from the in vitro antitumor screen of the national cancer institute. In Foye WO, ed. Cancer Chemotherapeutic Agents. American Chemical Society, Washington, DC, USA, pp 9-45.
86. Shi LM, Myers TG, Fan Y, O'Connor PM, Paull KD, Friend SH, Weinstein JN. 1998. Mining the national cancer institute anticancer drug discovery database: Cluster analysis of ellipticine analogs with p53-inverse and central nervous system-selective patterns of activity. Mol Pharmacol 53:241-251.
87. Shi LM, Fan Y, Myers TG, Waltham M, Paull KD, Weinstein JN. 1998. Mining the anticancer activity database generated by the nci anticancer drug discovery program using statistical and artificial intelligence techniques. Mathematical Modelling and Scientific Computing Vol 9.
88. Weinstein JN, Myers TG, O'Connor PM, Friend SH, Fornace AJ Jr, Kohn KW, Fojo T, Bates SE, Rubinstein LV, Anderson NL, Buolamwini JK, van Osdol WW, Monks AP, Scudiero DA, Sausville EA, Zaharevitz DW, Bunow B, Viswanadhan VN, Johnson GS, Wittes RE, Paull KD. 1997. An information-intensive approach to the molecular pharmacology of cancer. Science 275:343-349.
89. Shi LM, Fan Y, Lee JK, Waltham M, Andrews DT, Scherf U, Paull KD, Weinstein JN. 2000. Mining and visualizing large anticancer drug discovery databases. J Chem Inf Comput Sci 40:367-79.
90. Weinstein JN, Kohn KW, Grever MR, Viswanadhan VN, Rubinstein LV, Monks AP, Scudiero DA, Welch L, Koutsoukos AD, Chiausa AJ, and others. 1992. Neural computing in cancer drug development: Predicting mechanism of action. Science 258:447-451.
91. Weinstein JN, Myers T, Buolamwini J, Raghavan K, van Osdol W, Licht J, Viswanadhan VN, Kohn KW, Rubinstein LV, Koutsoukos AD, Monks A, Scudiero DA, Anderson NL, Zaharevitz DW, Chabner BA, Grever MR, Paull KD. 1994. Predictive statistics and artificial intelligence in the U.S. National cancer institute's drug discovery program for cancer and aids. Stem Cells 12:13-22.
92. Jackson MA, Stack HF, Waters MD. 1997. Activity profiles of carcinogenicity data - Application in hazard identification and risk assessment. Mutat Res 394:113-124.
93. Hileman B. 1994. Environmental estrogens linked to reproductive abnormalities, cancer. Chem Eng News 72:19-23.
94. Hileman B. 1997. Hormone disrupter research expands. Chem Eng News 75:24-25.
95. U.S. Code. 1996. Food Quality Protection Act: PL 104-170. et seq.
96. U.S. Code. 1996. Safe Drinking Water Act: Public law 104-182. Title 21 U.S. Congress $S 346a.97.
97. Gray LE Jr. 1998. Tiered screening and testing strategy for xenoestrogens and antiandrogens. Toxicol Lett 102-103:677-80.
98. Patlak M. 1996. A testing deadline for endocrine disrupters. Environ Sci Technol 30:540A-544A.
99. Tong W, Perkins R, Strelitz R, Collantes ER, Keenan S, Welsh WJ, Branham WS, Sheehan DM. 1997. Quantitative structure-activity relationships (QSARs) for estrogen binding to the estrogen receptor: Predictions across species. Environ Health Perspect 105:1116-1124.
100. Fang H, Tong W, Perkins R, Soto A, Prechtl N, Sheehan DM. 2000. Quantitative comparison of in vitro assays for estrogenic activity. Environ Health Perspect 108:723-729.
101. Blair R, Fang H, Branham WS, Hass B, Dial SL, Moland CL, Tong W, Shi L, Perkins R, Sheehan DM. 2000. Estrogen receptor relative binding affinities of 188 natural and xenochemicals: Structural diversity of ligands. Toxicol Sci 54:138-153.
102. Tong W, Perkins R, Fang H, Hong H, Xie Q, Branham W, Sheehan D, Anson J. 2002. Development of quantitative structure-activity relationships (QSARs) and their use for priority setting in testing strategy of endocrine disruptors. Regulatory Research Perspectives 1:1-16.
103. Walker JD, Fang H, Perkins R, Tong W. 2003. QSARs for EDPSD 2: The integrated 4-phase model. QSAR Comb Sci 22 (in press).
104. Shi L, Tong W, Fang H, Xie Q, Hong H, Perkins R, Wu J, Tu M, Blair RM, Branham WS, Waller C, Walker J, Sheehan DM. 2002. An integrated "4-phase" approach for setting endocrine disruption screening priorities - phase I and II predictions of estrogen receptor binding affinity. SAR/QSAR Environ Res 13:69-88.
105. Shi LM, Fang H, Tong W, Wu J, Perkins R, Blair R, Branham W, Sheehan D. 2001. QSAR models using a large diverse set of estrogens. J Chem Inf Comput Sci 41:186-195.
106. Brown SD, Blank TB, Sum ST, Weyer LG. 1994. Chemometrics. Anal Chem 66:315R-359R.
107. Hawkins DM, Young SS, Rusinko III A. 1997. Analysis of large structure-activity data set using recursive partitioning. Quant Struct-Act Relat 16:296-302.
108. Engels MF, Thielemans T, Verbinnen D, Tollenaere JP, Verbeeck R, 2000. Cerberus: A system supporting the sequential screening process. J Chem Inf Comput Sci 40:241-245.
109. Arabie P, Hubert LJ, De Soete G. 1996. Clustering and Classification. World Scientific Singapore, Singapore.
110. Mirkin BG. 1996. Mathematical Classification and Clustering. Kluwer Academic, Boston, MA, USA.
111. Timm GE, Darr JF, Flessner CJ, Kennedy PW, Maciorowski AF, O'Bryan TR, Walker D. 2003. Priority setting and framework for endocrine disruptor screening. In Katz SA, Salem H, eds, Alternative Toxicological Methods for the New Millennium. CRC, Boca Raton, FL, USA, (in press).
112. Murtagh E. 1985. Multidimensional Clustering Algorithms. Physica-Verlag, Vienna, Austria.
113. Guenoche A, Hassen P, Jaumard B. 1991. Efficient algorithms for divisive hierarchical clustering with the diameter criterion. Journal of Classification 8:5-30.
114. Xing L, Welsh WJ, Tong W, Perkins R, Sheehan DM. 1999. Comparison of estrogen receptor alpha and beta subtypes based on comparative molecular field analysis (CoMFA). SAR/QSAR Environ Res 10:215-237.
115. Brown RD, Martin YC. 1997. The information content of 2D and 3D structural descriptors relevant to ligand-receptor binding. J Chem Inf Comput Sci 37:1-9.
116. Kohonen T. 1995. Self-Organization Maps, Springer-Verlag, Berlin, Germany.
117. Simon V, Gasteiger J, Zupan JA. 1993. Combined application of two different neural network types for the prediction of chemical reactivity. J Am Chem Soc 115:9148-9159.
118. Polanski J, Jarzembek K, Gasteiger J. 2000. Self-organizing neural networks for screening and development of novel artificial sweetener candidates. Comb Chem High Throughput Screening 3:481-495.
119. Tetko IV, Kovalishyn VV, Livingstone DJ. 2001. Volume learning algorithm artificial neural networks for 3D QSAR studies. J Med Chem 44:2411-2420.
120. Sadowski J. 2000. Optimization of chemical libraries by neural networks. Curr Opin Chem Biol 4:280-282.
121. Sherlock G. 2000. Analysis of large-scale gene expression data. Curr Opin Immunol 12:201-205.
122. Tamayo P, Slonim D, Mesirov J, Zhu Q, Kitareewan S, Dmitrovsky E, Lander ES, Golub TR. 1999. Interpreting patterns of gene expression with self-organizing maps: Methods and application to hematopoietic differentiation. Proc Natl Acad Sci USA 96:2907-2912.
123. Livingstone D. 1995. Data Analysis for Chemists - Applications to QSAR and Chemical Product Design. Oxford University Press, New York, NY, USA.
124. Wold S. 1976. Pattern recognition by means of disjoint principal components models. Pattern Recogn 8:127-139.
125. Welsh WJ, Lin W, Tersigni SH, Collantes E, Duta R, Carey MS, Zielinski WL, Brower J, Spencer JA, Layloff TP. 1996. Pharmaceutical fingerprinting: Evaluation of neural networks and chemometric techniques for distinguishing among same-product manufacturers. Anal Chem 68:3473-3482.
126. Collantes ER, Duta R, Welsh WJ, Zielinski WL, Brower J. 1997. Preprocessing of HPLC trace impurity patterns by wavelet packets for pharmaceutical fingerprinting using artificial neural networks. Anal Chem 69:1392-1397.
127. Tetko IV, Villa AE, Aksenova TI, Zielinski WL, Brower J, Collantes ER, Welsh WJ. 1998. Application of a pruning algorithm to optimize artificial neural networks for pharmaceutical fingerprinting. J Chem Inf Comput Sci 38:660-668.
128. Zielinski WL, Brower JF, Welsh WJ, Collantes ER, Layloff TP. 1998. A strategy for developing consistent hplc data for assessing sameness and difference in consistency of pharmaceutical products. American Pharmaceutical Reviews 1:44-54.
129. Aksenova TI, Tetko IV, Ivakhnenko AG, Villa AE, Welsh WJ, Zielinski WL. 1999. Pharmaceutical fingerprinting in phase space. 1. Construction of phase fingerprints. Anal Chem 71:2423-2430.
130. Aksenova TI, Tetko IV, Ivakhnenko AG, Villa AE, Welsh WJ, Zielinski WL. 1999. Pharmaceutical fingerprinting in phase space. 2. Construction of phase fingerprints. Anal Chem 71:2431-2439.
131. Tetko IV, Aksenova TI, Volkovich VV, Kasheva TN, Filipov DV, Welsh WJ, Livingstone DJ, Villa AEP. 2000. Polynomial neural network for linear and non-linear model silection in quantitative-structure activity relationship studies on the internet. SAR/QSAR Environ Res 11:263-280.
132. Rusinko A, III, Farmen MW, Lambert CG, Brown PL, Young SS. 1999. Analysis of a large structure/biological activity data set using recursive partitioning. J Chem Inf Comput Sci 39:1017-1026.
133. Izrailev S, Agrafiotis D. 2001. A novel method for building regression tree models for QSAR based on artificial ant colony systems. J Chem Inf Comput Sci 41:176-180.
134. Morgan JN, Sonquist JA. 1963. Problems in the analysis of survey data, and a proposal. J Am Stat Assoc 58:415-434.
135. Breiman L, Friedman JH, Olshen RA, Stone CJ. 1984. Classification and Regression Trees. Wadsworth, Pacific Grove, CA, USA.
136. Breiman L, Friedman J, Olshen R, Stone C, Steinberg D, Colla P. 1995. Cart: Classification and regression trees, 4.0. Salford System, Stanford, CA, USA.
137. Kass GV. 1980. An exploratory technique for investigating large quantities of categorical data. Applied Statistics 29:119-127.
138. Quinlan J. 1993. C4.5: Programs for Machine Learning. Morgan Kauffman, San Francisco, CA, USA.
139. Clark LA, Pregibon D. 1992. Tree-Based Models. Thomson/Wadsworth, Stamford, CT, USA.
140. Anstead GM, Carlson KE, Katzenellenbogen JA. 1997. The estradiol pharmacophore: Ligand structure-estrogen receptor binding affinity relationships and a model for the receptor binding site. Steroids 62:268-303.
141. Stanton DT, Jurs PC. 1990. Development and use of charge partial surface area structural descriptors in computer-aided quantitative structure-property relationship studies. Anal Chem 62:2323-2329.
142. Rohrbaugh RH, Jurs PC. 1987. Descriptions of molecular shape applied in studies of structure/activity and structure/property relationships. Analytica Chimica Acta 199:99-109.
143. Zupan JA, Gasteiger J. 1993. Neural Networks for Chemists. VCH, Weinheim, Germany.
144. Kovesdi I, Dominguez-Rodriguez MF, Orfi L, Naray-Szabo G, Varro A, Papp JG, Matyus P. 1999. Application of neural networks in structure-activity relationships. Medical Research Reviews 19:249-269.
145. Manallack DT, Livingstone DJ. 1999. Neural networks in drug discovery: Have they lived up to their promise? Eur J Med Chem 34:195-208.
146. Alon U, Barkai N, Notterman DA, Gish K, Ybarra S, Mack D, Levine AJ. 1999. Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. Proc Natl Acad Sci USA 96:6745-6750.
147. NetWatch. 1999. Site visit: Dipping into DNA chips. Science 285:799.
148. Bassett DE Jr, Eisen MB, Boguski MS. 1999. Gene expression informatics-it's all in your mine. Nat Genet 21 (Suppl 1):51-55.
149. Spellman PT, Sherlock G, Zhang MQ, Iyer VR, Anders K, Eisen MB, Brown PO, Botstein D, Futcher B. 1998. Comprehensive identification of cell cycle-regulated genes of the yeast saccharomyces cerevisiae by microarray hybridization. Mol Biol Cell 9:3273-3297.
150. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, Coller H, Loh ML, Downing JR, Caligiuri MA, Bloomfield CD, Lander ES. 1999. Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring. Science 286:531-537.
151. Kalocsai P, Shams S. 1999. Visualization and anaylsis of gene expression data. Journal of the Association of Laboratory Antomation 4:58-61.
152. Hong H, Tong W, Fang H, Shi LM, Xie Q, Wu J, Perkins R, Walker J, Branham W, Sheehan D. 2002. Prediction of estrogen receptor binding for 58,000 chemicals using an integrated computational approach. Environ Health Perspect 110:29-36.
153. Walker JD, Fang H, Perkins R, Tong W. 2003. QSARs for endocrine disruption priority setting database 2: The integrated 4-phase model. Quant-Struct Act Relat 22:89-105.
154. Branham WS, Dial SL, Moland CL, Hass B, Blair R, Fang H, Shi L, Tong W, Perkins R, Sheehan DM. 2000. Phytoestrogen and mycoestrogen binding to rat uterine estrogen receptor. Am J Nutr 132:658-664.
155. Matthews EJ, Benz RD, Contrera JF. 2000. Use of toxicological information in drug design. J Mol Graph Model 18:605-615.
156. Johnson DE. 2001. The optimal fragmentation principle. Drug Discov Today 6:175.
157. Richard AM. 2001. The optimal fragmentation principle-reply. Drug Discovery Today 6:235-237.